SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-019000
Filing Date
2018-01-25
Accepted
2018-01-25 07:00:03
Documents
3
Period of Report
2018-01-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d530662d8k.htm 8-K 17908
2 EX-99 d530662dex991.htm EX-99.1 13753
3 GRAPHIC g530662img001.jpg GRAPHIC 13540
  Complete submission text file 0001193125-18-019000.txt   51331
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 18546617
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1